Seeing Is Believing

Currently out of the existing stock ratings of Jack Meehan, 47 are a BUY (47%), 34 are a HOLD (34%), 19 are a SELL (19%).
Analyst Jack Meehan, currently employed at BARCLAYS, carries an average stock price target met ratio of 91.64% that have a potential upside of 29.47% achieved within 295 days. Previously, Jack Meehan worked at STIFEL.
Jack Meehan’s has documented 211 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Consumer Cyclical, Basic Materials sectors.
Most recent stock forecast was given on LH, Laboratory of America Holdings at 02-Oct-2025.
Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for INMD (INMODE LTD) at 11/6/2019. The price target of $22.5 was fulfilled within 5 days with a profit of $3.07 (15.8%) receiving and performance score of 31.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Jan-2026
$90
2 months 20 days ago
(12-Jan-2026)
1/5 (20%)
$23.67 (35.69%)
343
Hold Since 05-Jan-2026
$78
$2.33 (3.08%)
$78
2 months 27 days ago
(05-Jan-2026)
22/25 (88%)
$3.25 (4.35%)
183
Hold Since 28-Jul-2022
$76
4 months 21 days ago
(11-Nov-2025)
7/13 (53.85%)
$1.7 (2.29%)
62
Hold Since 23-Oct-2025
$78
$2.33 (3.08%)
$70
5 months 9 days ago
(23-Oct-2025)
5/14 (35.71%)
$4.11 (5.56%)
90
Hold Since 22-Oct-2025
$76
$0.33 (0.44%)
$78
5 months 10 days ago
(22-Oct-2025)
1/6 (16.67%)
$2.07 (2.80%)
160
What Year was the first public recommendation made by Jack Meehan?